|
PF-30219 |
BACTROBAN 2% ungüento topico |
2008-04-08 |
|
Glaxosmithkline Argentina S.A. |
Argentina
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50889 |
VENTOLIN ROTACAPS 200 mcg Cápsulas con polvo para inhalación |
2019-12-01 |
|
Glaxosmithkline Australia Pty Ltd |
Australia
|
J.I.Cohen, S.A. |
Amicelco |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52185 |
VENTOLIN NEBULES 2.5 mg/2.5 mL Solución para inhalación |
2025-01-10 |
|
Glaxosmithkline Australia Pty Ltd |
Australia
|
J.I.Cohen, S.A. |
Amicelco |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54940 |
FLIXOTIDE NEBULES 0.5 mg/2 mL Suspensión para inhalación |
2023-02-08 |
|
Glaxosmithkline Australia Pty Ltd |
Australia
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39521 |
RELENZA 5 mg Polvo para inhalación |
2012-09-27 |
|
Glaxosmithkline PLC |
Australia
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52619 |
FLUARIX TETRA Suspensión inyectable |
2026-03-22 |
|
GlaxoSmithKline Biologicals, Alemania |
Alemania
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28862 |
FLUARIX Suspensión inyectable |
2017-10-02 |
|
GlaxoSmithKline Biologicals, Alemania |
Alemania
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54730 |
ENGERIX B Dosis Pediátrica 10 mcg/0.5 mL Suspensión inyectable |
2022-12-06 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55010 |
TWINRIX Suspensión inyectable |
2023-03-09 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35399 |
ROTARIX Liofilizado para Suspension Oral |
2010-05-20 |
|
Glaxosmithkline Mexico, S.A De C.V. |
Bélgica
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|